Perspectives on Metastatic Hormone-Sensitive Prostate Cancer | Bayer скачать в хорошем качестве

Perspectives on Metastatic Hormone-Sensitive Prostate Cancer | Bayer

Professor Daniel George, MD, Director of GU Oncology at Duke University in North Carolina, shares his thoughts on types of prostate cancer, the unmet medical needs in metastatic-hormone sensitive prostate cancer, advances in prostate cancer treatment, as well as the importance of quality of life for people living with the disease. 00:00 - Introduction 00:07 - What are the different disease stages in prostate cancer? 01:04 - What is metastatic hormone-sensitive prostate cancer? 01:22 - What is the prognosis for those diagnosed with metastatic hormone-sensitive prostate cancer? 01:53 - What does the treatment landscape look like in metastatic hormone-sensitive prostate cancer? 02:39 - What are the current unmet medical needs in metastatic hormone-sensitive prostate cancer? 03:27 - Which treatment outcomes are most important to patients with metastatic hormone-sensitive prostate cancer? 03:50 - How important is maintaining quality of life for you when you discuss treatment options with your patients? 04:57 - What impact can treatment related adverse events have on treatment adherence and can this impact patient outcomes? 05:43 - What can the medical community do to continue supporting patients living with metastatic hormone-sensitive prostate cancer?